| scholarly article | Q13442814 |
| P2093 | author name string | Michael R Nichols | |
| Deepa Ajit | |||
| Geeta Paranjape | |||
| Maria L D Udan | |||
| P2860 | cites work | RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease | Q24314906 |
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 | ||
| Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo | Q28131779 | ||
| Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines | Q28297800 | ||
| Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis | Q29547501 | ||
| Intracellular amyloid-beta in Alzheimer's disease | Q29615626 | ||
| Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils | Q29617476 | ||
| The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease | Q30432239 | ||
| Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques | Q30486499 | ||
| beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. | Q31840031 | ||
| Conformational Abs recognizing a generic amyloid fibril epitope | Q34009881 | ||
| In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis | Q34166792 | ||
| Intrathecal inflammation precedes development of Alzheimer's disease | Q35476365 | ||
| Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease | Q35689983 | ||
| ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA | Q35869454 | ||
| Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases | Q35934211 | ||
| Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. | Q35969894 | ||
| Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers | Q36178075 | ||
| Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide | Q36684459 | ||
| Toll-like receptors 2 and 4 mediate Abeta(1-42) activation of the innate immune response in a human monocytic cell line | Q40055691 | ||
| Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. | Q40056685 | ||
| A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. | Q40657503 | ||
| Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease | Q40870408 | ||
| Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia | Q40897569 | ||
| Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? | Q40918121 | ||
| Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha | Q41132584 | ||
| Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils | Q41173971 | ||
| beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes | Q41195097 | ||
| In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity | Q44418518 | ||
| Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology. | Q45140488 | ||
| Abeta peptide conformation determines uptake and interleukin-1alpha expression by primary microglial cells | Q46703067 | ||
| Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. | Q46733868 | ||
| Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide | Q47337531 | ||
| The LPS receptor (CD14) links innate immunity with Alzheimer's disease | Q47405789 | ||
| Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease | Q48157079 | ||
| Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. | Q48219387 | ||
| The importance of inflammatory mechanisms in Alzheimer disease | Q48380991 | ||
| Inflammation takes on Alzheimer disease. | Q48495966 | ||
| Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. | Q48614187 | ||
| Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. | Q48963826 | ||
| Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. | Q51811574 | ||
| Activation of microglial cells by beta-amyloid protein and interferon-gamma. | Q53202007 | ||
| Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. | Q53218877 | ||
| Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. | Q53248798 | ||
| In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein. | Q53371986 | ||
| Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR | Q57101951 | ||
| Insights into the amyloid folding problem from solid-state NMR | Q57188281 | ||
| Observation of metastable Abeta amyloid protofibrils by atomic force microscopy | Q73431442 | ||
| Inflammatory factors are elevated in brain microvessels in Alzheimer's disease | Q77384320 | ||
| Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates | Q78177648 | ||
| P433 | issue | 38 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9011-9021 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | Amyloid-beta(1-42) fibrillar precursors are optimal for inducing tumor necrosis factor-alpha production in the THP-1 human monocytic cell line | |
| P478 | volume | 48 |
| Q39446552 | 14-3-3ε marks the amyloid-stimulated microglia long-term activation |
| Q42928266 | From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer's disease |
| Q37419866 | Inflaming the diseased brain: a role for tainted melanins |
| Q36109443 | Isolated amyloid-β(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia |
| Q35881879 | Nucleotides released from Aβ₁₋₄₂ -treated microglial cells increase cell migration and Aβ₁₋₄₂ uptake through P2Y₂ receptor activation |
| Q53347422 | Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway. |
| Q36489865 | Stability of early-stage amyloid-β(1-42) aggregation species |
| Q35327219 | The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease |
Search more.